Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis
Authors:
Open Access
- 14 August 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 64 (4) , 877-878
Abstract
We would like to acknowledge Professor Dr J. de Hoon (Centre for Clinical Pharmacology), Professor Dr P. Augustijns and Pharm. J. Walravens (Laboratory for BiopKeywords
This publication has 12 references indexed in Scilit:
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #Hepatology, 2009
- Voriconazole in the treatment of fungal eye infections: a review of current literatureBritish Journal of Ophthalmology, 2008
- Entecavir resistance is rare in nucleoside naïve patients with hepatitis BHepatology, 2006
- Challenges and obstacles of ocular pharmacokinetics and drug deliveryAdvanced Drug Delivery Reviews, 2006
- Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2006
- A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis BNew England Journal of Medicine, 2006
- Successful Treatment of Fusarium Endophthalmitis With Voriconazole and Aspergillus Endophthalmitis With Voriconazole Plus CaspofunginAmerican Journal of Ophthalmology, 2005
- Subtherapeutic Ocular Penetration of Caspofungin and Associated Treatment Failure in Candida albicans EndophthalmitisClinical Infectious Diseases, 2005
- Candida glabrata Endophthalmitis Treated Successfully with CaspofunginClinical Infectious Diseases, 2005
- Do climatic variables influence the development of posterior vitreous detachment?British Journal of Ophthalmology, 2002